FRES Wutah pendapatan kuartal marang kuartal Fresh2

Fresh2 Group (FRES) - logo korporat

Fresh2 Group Limited lacks market influence and suffers from dumping due to the absence of a stable commercial base. This quarterly revenue growth chart demonstrates local dynamics, where the parameter value reaches 26.20. The development of an agro-logistics IT service through partnerships with restaurateurs coexists with geopolitical risks that hinder patent protection and global component supplies for diagnostics.

FRES (Fresh2 Group Limited) riwayat Tambahing pendapatan triwulanan saka 21.02.2024 nganti 04.01.2025

Ringkesan rincian data analitis Fresh2 Group Limited (FRES)

- rega saham lan target rega konsensus:
Pambiji fundamental perusahaan:FRES Fresh2 Group Ltd
Produk mawa merek Fresh2

Fresh2 Group Limited's expansion into the high-precision biotechnological diagnostics segment depends directly on scaling the implementation of its laboratory platforms. By analyzing the magnitude of quarterly revenue growth, investors assess the dynamics of real demand for rapid tests, where a stable upward trend confirms the business's fundamental resilience and the absence of artificial sales inflation amid high capital costs.

Analisis pesaing Fresh2 Group Limited

A - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Quest Diagnostics Incorporated DGX|ILMN (illumina.com) - Wutah dodolan triwulanan|Wutah dodolan triwulanan Cologuard|RVTY (Revvity Corp) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Bio-Rad Laboratories Inc|Wutah dodolan triwulanan NNNN (Anbio Biotechnology)|SHC (Sotera Health Company) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal QuidelOrtho Inc. QDEL|Wutah pendapatan triwulanan OPKO Health Inc OPK|CareDx Inc - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan MRVI (Maravai)|FLGT: Wutah pendapatan triwulanan|LAB (Standard BioTools Inc.) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Cytek Biosciences Inc|Tingkat wutah pendapatan sajrone kuartal OraSure OSUR|Wutah dodolan triwulanan XGN (Exagen Diagnostics)|Tingkat wutah dodolan sajrone kuartal MDxHealth Inc.|Wutah pendapatan kuartal marang kuartal Lucid Diagnostics, Inc. LUCD|Prenetics Global Ltd (PRE) - Tingkat wutah pendapatan sajrone kuartal|Insight Molecular Diagnostics Inc - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal trinitybiotech.com|PRPH (ProPhase) - Wutah dodolan triwulanan|Wutah dodolan kuartal marang kuartal AIMD|Wutah dodolan triwulanan CODX|Tingkat wutah pendapatan sajrone kuartal heartsciences.com HSCS|Wutah pendapatan kuartal marang kuartal Biomerica Inc. (BMRA)|Tingkat wutah dodolan sajrone kuartal Cardio Diagnostics Holdings|Wutah pendapatan triwulanan ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Tingkat wutah pendapatan sajrone kuartal|bluejaydx.com - Wutah pendapatan triwulanan|Aspira Women's Health - Owah-owahan dodolan kuartal marang kuartal|AXDX (Accelerate Diagnostics) - Wutah dodolan triwulanan|Wutah dodolan triwulanan CENTOGENE, N.V.|Wutah pendapatan kuartal marang kuartal enzo.com|Genetic Technologies (GENE) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan ME|Wutah pendapatan kuartal marang kuartal PMD (Psychemedics Corporation)